Orchestra Bio — Valuation, Funding & Investors

Is this your company? Get featured or correct your listing →

Suggest a correction

We're still building this profile — here is what Pulse has covered.

Latest Pulse

Oct 20, 2026OpenAI Acquires AI Biotech Startup Orchestra BioOpenAI acquired four-year-old AI biotech startup Orchestra Bio, whose agents handle operational work in drug discovery, folding its team into OpenAI's Rosalind life-sciences platform; deal terms were not disclosed.→

Coverage Timeline

newest first

Oct 20, 2026AIOpenAI Acquires AI Biotech Startup Orchestra Bio→

All Coverage

AI· Oct 20, 2026

OpenAI Acquires AI Biotech Startup Orchestra Bio

OpenAI acquired four-year-old AI biotech startup Orchestra Bio, whose agents handle operational work in drug discovery, folding its team into OpenAI's Rosalind life-sciences platform; deal terms were not disclosed.

Oct 20, 2026DEEP DIVE

Related Companies

Same sector

Scribe Therapeutics Attovia Therapeutics Iambic Therapeutics Apnimed Retension Pharmaceuticals Eli Lilly